Publications by authors named "Gregory Pogue"

Claim this Profile
M
Manufacturing plant-made monoclonal antibodies for research or therapeutic applications.
Kelsi Swope, Josh Morton, Gregory P Pogue, Steve Hume, Michael H Pauly

Methods Enzymol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility and flexibility of monoclonal antibody production with .
Kelsi Swope, Josh Morton, Gregory P Pogue, Leigh Burden, Nicholas Partain

MAbs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology.
Jennifer K DeMarco, Joshua M Royal, William E Severson, Jon D Gabbard, Steve Hume, Gregory P Pogue

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle.
Joshua M Royal, Carrie A Simpson, Alison A McCormick, Amanda Phillips, Steve Hume, Gregory P Pogue

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Genomic Technologies in Clinical Pharmacology Research.
Rafael Baltazar Reyes León-Cachón, Jorge Ángel Isidro Ascacio-Martínez, Magdalena Gómez-Silva, Everardo Piñeyro-Garza, José Gerardo González-González, Gregory Pogue

Rev Invest Clin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.
Jyothi K Mallajosyula, Ernie Hiatt, Steve Hume, Ashley Johnson, Trushar Jeevan, Gregory P Pogue

Hum Vaccin Immunother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of recombinant antigens and antibodies in Nicotiana benthamiana using 'magnifection' technology: GMP-compliant facilities for small- and large-scale manufacturing.
Victor Klimyuk, Gregory Pogue, Stefan Herz, John Butler, Hugh Haydon

Curr Top Microbiol Immunol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.
Gregory P Pogue, Fakhrieh Vojdani, Kenneth E Palmer, Ernie Hiatt, Steve Hume

Plant Biotechnol J· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
Barry R O'Keefe, Fakhrieh Vojdani, Viviana Buffa, Robin J Shattock, David C Montefiori, Gregory P Pogue

Proc Natl Acad Sci U S A· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeras between oilseed rape mosaic virus and tobacco mosaic virus highlight the relevant role of the tobamoviral RdRp as pathogenicity determinant in several hosts.
Carmen Mansilla, Flora Sánchez, Hal S Padgett, Gregory P Pogue, Fernando Ponz

Mol Plant Pathol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice.
Hong Du, Terri L Cameron, Stephen J Garger, Gregory P Pogue, Lee A Hamm

J Lipid Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-omics and cancer biomarkers: emerging tools and technologies for the medical laboratory.
Gregory P Pogue, Grant Gibson, J Donald Capra

MLO Med Lab Obs· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection.
Alison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, Kenneth E Palmer, Gregory P Pogue

Bioconjug Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
Mark L Smith, Tina Corbo, Jacqueline Bernales, John A Lindbo, Gregory P Pogue

Virology· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.
Alison A McCormick, Tina A Corbo, Sherri Wykoff-Clary, Long V Nguyen, Mark L Smith, Gregory P Pogue

Vaccine· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.
Kenneth E Palmer, Ann Benko, Sarah A Doucette, Terri I Cameron, Tiffany Foster, Gregory P Pogue

Vaccine· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic modification of plants with systemic RNA viruses.
Wayne P Fitzmaurice, Steve Holzberg, John A Lindbo, Hal S Padgett, Kenneth E Palmer, Gregory P Pogue

OMICS· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressor of RNA silencing encoded by Beet yellows virus.
Jonathan C Reed, Kristin D Kasschau, Alexey I Prokhnevsky, Kodetham Gopinath, Gregory P Pogue

Virology· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a plant viral-vector-based gene expression assay for the screening of yeast cytochrome p450 monooxygenases.
Kathleen Hanley, Long V Nguyen, Faizah Khan, Gregory P Pogue, Fakhrieh Vojdani

Assay Drug Dev Technol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making an ally from an enemy: plant virology and the new agriculture.
Gregory P Pogue, John A Lindbo, Stephen J Garger, Wayne P Fitzmaurice

Annu Rev Phytopathol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of calreticulin P-domain results in impairment of secretory pathway in Leishmania donovani and reduced parasite survival in macrophages.
Alain Debrabant, Nancy Lee, Gregory P Pogue, Dennis M Dwyer, Hira L Nakhasi

Int J Parasitol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of the movement and host range properties of a plant virus vector through DNA shuffling.
Rachel L Toth, Gregory P Pogue, Sean Chapman

Plant J· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barley stripe mosaic virus-induced gene silencing in a monocot plant.
Steve Holzberg, Paul Brosio, Cynthia Gross, Gregory P Pogue

Plant J· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis